A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) in Patients With Advanced Basal Cell Carcinoma
Clinical trial NCT00833417 · COMPLETED
Trial details
- NCT number
- NCT00833417
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-10
- Primary completion
- 2010-11-26
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.